Finke, Carsten
Mohr, Peter http://orcid.org/0009-0004-6591-7570
Article History
Received: 14 March 2024
Accepted: 22 April 2024
First Online: 28 May 2024
Declarations
:
: Dr. med. Peter Mohr has received payments or honoraria from MSD Pharma GmbH, Novartis, Bristol Myers Squibb, Pierre Fabre, Sanofi-Genzyme, Roche Pharma AG, Beiersdorf AG, Amgen, Almirall Hermal GmbH, Sun Pharma, and Regeneron Pharmaceuticals; support for attending meetings and/or travel from MSD, Bristol Myers Squibb, Pierre Fabre, Sun Pharma and Regeneron; and he has held unpaid leadership or fiduciary roles in MID Melanom Info Deutschland, as well as HKND Hautkrebs Netzwerk Deutschland. He is affiliated to the Clinique of Dermatology, Buxtehude, Germany. Carsten Finke has nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Carsten Finke provided written informed consent for identifying his personal data in this case report.